Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Pulmonary Fibrosis Clinical Trials
Pulmonary Fibrosis clinical trials are recruiting across 83 cities. Here are the cities with the most active studies:
Pulmonary Fibrosis Trial Phases
35 research organizations are sponsoring pulmonary fibrosis trials.
About Pulmonary Fibrosis
Pulmonary fibrosis is a condition in which the lung tissue becomes damaged and scarred, making it difficult for the lungs to function properly. Idiopathic pulmonary fibrosis (IPF) is the most common form with unknown cause. Antifibrotic medications can slow progression, and lung transplant may be considered.
Clinical trials are advancing new treatments for pulmonary fibrosis. Currently, 50 studies are recruiting a combined 30,966 participants across the United States. Research is being conducted by 35 organizations including Pulmonary Fibrosis Foundation, University of Chicago, Duke University and 32 others.
2026 Pulmonary Fibrosis Research Landscape
As of July 2026, the pulmonary fibrosis clinical trial landscape includes 50 actively recruiting studies across 83 cities in the United States. These studies are collectively seeking 30,966 participants, with an average enrollment target of 619 per study.
The research spans multiple phases of development: 19 studies are in PHASE2, 6 studies are in PHASE3, 6 studies are in PHASE1, 3 studies are in NA, 2 studies are in EARLY_PHASE1. The presence of Phase 3 trials indicates that some pulmonary fibrosis treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 35 different organizations, including Pulmonary Fibrosis Foundation, University of Chicago, Duke University, University of Pittsburgh, Boehringer Ingelheim, and 30 others. The large number of sponsors reflects significant research interest and investment in pulmonary fibrosis treatment advancement.
Geographically, pulmonary fibrosis trials are most concentrated in Los Angeles, California (14 trials); Birmingham, Alabama (11 trials); Kansas City, Kansas (8 trials); Denver, Colorado (6 trials); Durham, North Carolina (6 trials) and 7 other cities.
Featured Pulmonary Fibrosis Studies
Highlighted recruiting studies for pulmonary fibrosis, selected by enrollment size and research scope.
Pulmonary Fibrosis Foundation Community Registry
Pulmonary fibrosis (PF) results from a diverse group of health conditions and affects the lives of patients (including those who are post lung transplant), caregivers and family members. The Pulmonary Fibrosis Foundation Community Registry will offer an online portal where participants can self-enroll and directly contribute information about their experience with PF to be compiled into a longitud...
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
The Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry started recruiting in 2014 with the objective of studying Idiopathic Pulmonary Fibrosis. In 2018, the registry expanded to include recruitment of participants with other chronic fibrosing interstitial lung diseases (ILDs) with progressive phenotype also referred to as progressive fibrosing interstitial lung diseases in the C...
Frequently Asked Questions About Pulmonary Fibrosis Clinical Trials
Are there pulmonary fibrosis clinical trials near me?
Yes, there are 50 pulmonary fibrosis clinical trials currently recruiting across 83+ cities in the United States, including Los Angeles, California; Birmingham, Alabama; Kansas City, Kansas. Browse the studies above to find one at a location convenient for you.
How do I join a pulmonary fibrosis clinical trial?
To join a pulmonary fibrosis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are pulmonary fibrosis clinical trials free?
Yes, participation in pulmonary fibrosis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of pulmonary fibrosis treatments are being studied?
Current pulmonary fibrosis clinical trials are testing a range of approaches across PHASE2 (19 studies), PHASE3 (6 studies), PHASE1 (6 studies), NA (3 studies), EARLY_PHASE1 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 35 research organizations.
Is it safe to participate in pulmonary fibrosis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov